Cable Hill Partners’s OncoSec Medical Incorporated ONCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-5
Closed -$1K 926
2018
Q2
$1K Sell
5
-13
-72% -$4.56K ﹤0.01% 880
2018
Q1
$8K Buy
18
+4
+29% +$1.64K ﹤0.01% 562
2017
Q4
$6K Buy
+14
New +$4.9K ﹤0.01% 712

Other funds holding ONCS

Cable Hill Partners's ONCS Position: Q3 2018 in Review

Cable Hill Partners sold out of OncoSec Medical Incorporated (ONCS) in Q3 2018, closing a stake of 5 shares — an estimated $1K sold.

Cable Hill Partners first reported a position in ONCS in Q4 2017 and held it in 3 quarters. The position peaked at $8K in Q1 2018. 32 funds tracked by Wall St. Rank hold ONCS as of Q3 2018.

  • Cable Hill Partners reported no remaining OncoSec Medical Incorporated position as of Q3 2018 after selling out during the quarter.
  • Cable Hill Partners sold 5 OncoSec Medical Incorporated shares in Q3 2018, an estimated $1K.
  • Cable Hill Partners first reported a position in OncoSec Medical Incorporated in Q4 2017 and held it in 3 quarters.
  • Cable Hill Partners's OncoSec Medical Incorporated position peaked at $8K in Q1 2018.
  • 32 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q3 2018.

Based on Cable Hill Partners's 13F filing for Q3 2018, filed 14 Nov 2018.